• Rempex Pharmaceuticals Appoints Jennifer Cayer New Chief Operating Officer More...

• Albany Molecular Research, Inc. (AMRI) (AMRI) Hires Director of In Vitro Biology in Singapore More...

• BioNeutral Appoints New Board of Directors Member and Seeks to Expand Its Management Team More...

• Valence Life Sciences Announces Promotion of Scott Morenstein and Hiring of Robert Ferraioli More...

• Amgen (AMGN) to Create 100 Jobs More...

• Johnson & Johnson (JNJ) CEO Gorsky Says Company Will Grow While Rivals Shrink More...

• Galena Biopharma (RXII) Takes Final Actions to Complete Spin-Off of RXi Pharmaceuticals (RXII) More...

• Galenea to Receive $6 Million From The Stanley Medical Research Instituteto Progress Pro-Cognitive Drug Discovery and Development Program More...

• Watson Pharmaceuticals, Inc. (WPI)'s $5.9 Billion for Actavis Earning Applause as Shares Pop More...

• Onyx Pharmaceuticals, Inc. (ONXX) Shares Rally Late Afternoon Amid Rumor of Bayer AG (BAY.F) Acquisition More...

• Baxter International, Inc. (BAX) Completes Purchase of SIGMA International More...

• Epizyme Gets $90 Million in Epigenetics Partnership With Celgene Corporation (CELG) More...

• Southern Research Institute Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings More...

• Evotec AG (EVTG.F) and Active Biotech AB (BTPC) Extend and Expand Medicinal Chemistry Collaboration More...

• Zalicus Inc. (ZLCS) Provides Oncology Research Collaboration Update More...

• Hi-Tech Pharmacal (HITK) Licenses Rights to Lidocaine 5% Ointment More...

• Active Biotech AB (BTPC) Interim Report January - March 2012 More...

• AVEO Pharmaceuticals, Inc. (AVEO) Announces Timing for First Quarter Financial Results, Webcast and Conference Call More...

• Alimera Sciences (ALIM) to Release First Quarter Fiscal Year 2012 Financial Results More...

• Acorda Therapeutics (ACOR) to Host Conference Call to Discuss First Quarter 2012 Financial Results on May 3, 2012 More...

• AmerisourceBergen Corporation (ABC) Reports $0.81 in Diluted EPS for the March Quarter More...

• Icahn Drops Suit After Making Nice With Amylin Pharmaceuticals, Inc. (AMLN) CEO More...

• Mylan Inc. (MYL) and Pfizer Inc. (PFE) Announce Epinephrine Auto-injector Settlement Agreement With Teva Pharmaceutical Industries Limited (TEVA) More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos Successor Fails to Win FDA OK More...

• Repligen Corporation (RGEN) Provides Regulatory Update for RG1068 New Drug Application; FDA Cancels Advisory Committee Meeting More...

• Onyx Pharmaceuticals, Inc. (ONXX) Says FDA's ODAC Will Review NDA For Carfilzomib More...

• Pfizer Inc. (PFE) Drug Reduced Autism Signs in Mice More...

• Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients With Major Depressive Disorder More...

• Shire plc (SHPGY) Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults With Binge Eating Disorder More...

• Omthera Pharmaceuticals, Inc. Announces Positive Top-Line Results from Phase 3 EVOLVE Study More...

• Banner Sun Health Research Institute Release: Study Findings Confirming Reliable Beta-Amyloid Imaging in the Living Brain Presented at American Academy of Neurology Annual Meeting in New Orleans More...

• Eating More Berries May Delay Memory Decline, Harvard Medical School Study More...

• Poor Sleep Heightens "Ringing Ear" Disease Symptoms, Henry Ford Health System Study More...

• Leafy Greens Help Prevent Damage Caused by a Workout, Edinburgh Napier University Study More...

• Switching Subject Categories Could Improve Test Scores, Syracuse University Study More...

• Feel-Good Music Helps With Psychological Counseling, Concordia University Study More...

• Apricus Biosciences (APRI) Receives Notice of Issuance for First Prevonco™ Patent in the United States More...

• Bio Scientific Corporation Introduces Optimized Directional RNA-Seq Kits With Innovative Bias Reducing Technology More...

• Tianyin Pharmaceutical Co, Inc. Provides Progress Updates on its GMOL Flagship Product More...

• Watson Pharmaceuticals, Inc. (WPI) and Antares Pharma, Inc. (AIS) Announce the Introduction of Gelnique™, for the Treatment of Overactive Bladder More...